<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Physiology and clinical manifestations of normal adrenarche</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Physiology and clinical manifestations of normal adrenarche</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Physiology and clinical manifestations of normal adrenarche</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard J Auchus, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Rosenfield, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mitchell E Geffner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Adrenarche is the term for the maturational increase in adrenal androgen production that normally becomes biochemically apparent by a rise in serum levels of the 19-carbon (C19) 17-ketosteroid androgen precursor dehydroepiandrosterone sulfate (DHEAS) at approximately six years of age in both girls and boys (<a class="graphic graphic_figure graphicRef79533" href="/d/graphic/79533.html" rel="external">figure 1</a>) [<a href="#rid1">1-3</a>]. It is characterized by production of increasing amounts of androgen precursors and smaller amounts of potent androgens (C19 17-beta-hydroxysteroids) by the zona reticularis of the adrenal cortex, which contribute to the development of pubic hair, sebaceous glands, and apocrine (sweat) glands.</p><p>Humans and some higher primates are unique in having an adrenal zone with such structure-function-developmental stage relationships [<a href="#rid4">4-9</a>]. In most children, the first appearance of pubic hair (pubarche) occurs shortly after other signs of pubertal development. In a minority of individuals, pubarche occurs before true puberty (eg, when adrenarche causes pubarche before true puberty begins [<a href="#rid10">10</a>] or in the presence of hypogonadism [<a href="#rid1">1</a>]). Thus, adrenarche is unrelated to the pubertal maturation of the hypothalamic-pituitary-gonadal axis.</p><p>Premature adrenarche is the most common cause of premature pubarche, defined as the isolated appearance of sexual hair before the age of eight years in girls and nine years in boys. This subject is discussed in detail in a separate topic review. (See  <a class="medical medical_review" href="/d/html/5806.html" rel="external">"Premature adrenarche"</a>.)</p><p class="headingAnchor" id="H24070873"><span class="h1">PHYSIOLOGY</span></p><p class="headingAnchor" id="H1968858983"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Adrenarche is the result of a developmental change in the pattern of adrenal secretory response to adrenocorticotropic hormone (ACTH) so that serum levels of dehydroepiandrosterone sulfate (DHEAS), 5-androstenediol-3-sulfate, and related 19-carbon (C19) steroids rise, while those of cortisol do not [<a href="#rid1">1,11</a>]. During adrenarche, the pattern of adrenal steroid levels changes in a unique way (<a class="graphic graphic_table graphicRef75217" href="/d/graphic/75217.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>In the preadrenarchal child, ACTH stimulates cortisol secretion but has very little effect on C19 steroids (eg, dehydroepiandrosterone [DHEA]) secretion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During adrenarche, the secretory pattern in response to ACTH gradually changes (<a class="graphic graphic_figure graphicRef53342" href="/d/graphic/53342.html" rel="external">figure 2</a>) [<a href="#rid11">11</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ACTH stimulates secretion of DHEAS and DHEA, their delta-5-steroid precursors (eg, 17-hydroxypregnenolone), and product 5-androstenediol more than it stimulates secretion of testosterone and its delta-4-steroid precursors (eg, 17-hydroxyprogesterone and androstenedione). Meanwhile, cortisol serum levels remain stable (<a class="graphic graphic_figure graphicRef58179" href="/d/graphic/58179.html" rel="external">figure 3</a>). In contrast, ACTH stimulation in the preadrenarchal child causes a different adrenal androgen secretory pattern, with a relative predominance of androstenedione over DHEA [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>DHEA is sulfated, predominantly within the zona reticularis, to form DHEAS. As a result, DHEAS becomes the predominant 17-ketosteroid in blood and main marker of adrenarche.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serum levels of androstenedione and testosterone increase slightly, so that they normally hover near the upper end of the prepubertal range during the early adrenarchal years (six to eight years of age).</p><p></p><p>These adrenarchal changes are ACTH dependent [<a href="#rid11">11,13</a>]; they recede when ACTH is suppressed (eg, by glucocorticoid therapy) [<a href="#rid14">14,15</a>]. However, they are not due to a change in ACTH secretion; rather, the increase in adrenal C19 steroid production reflects a qualitative change in the adrenal response to ACTH due to the development of the zona reticularis. The changes in the zona reticularis with normal growth and development are summarized in the figure (<a class="graphic graphic_figure graphicRef138813" href="/d/graphic/138813.html" rel="external">figure 4</a>) [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H2"><span class="h2">Differentiation of the adrenal zona reticularis</span><span class="headingEndMark"> — </span>The zona reticularis is the source of adrenarchal steroids (<a class="graphic graphic_figure graphicRef58179" href="/d/graphic/58179.html" rel="external">figure 3</a>) [<a href="#rid16">16,17</a>].</p><p>Adrenocortical stem and progenitor cells appear to be located in the capsular and subcapsular (outer zona glomerulosa) regions of the adrenal cortex, and daughter cells then proliferate toward the corticomedullary junction to establish the zones of the definitive adrenal cortex [<a href="#rid8">8,16</a>]. This development is initiated by a number of interactions involving differentiation and transcription factors that are critical for the formation of the zona glomerulosa. ACTH signaling via melanocortin receptor 2 and protein kinase A is critical for differentiation of the zona fasciculata and zona reticularis from precursor cells in the zona glomerulosa [<a href="#rid8">8,13,16,18</a>]. Low cholesterol concentrations in the zona reticularis appear to contribute to its biochemical phenotype [<a href="#rid19">19</a>].</p><p>The zona reticularis begins to form in the central adrenal cortex at three to four years of age. It appears in the site of the former fetal zone of the adrenal cortex, which it resembles in its DHEAS production, but develops from a cell type that is distinct from that of the fetal zone. During the preschool years, it continues to develop into a continuous zone, in which zona reticularis cells then proliferate as children grow [<a href="#rid20">20</a>] and adrenal androgen production subtly increases [<a href="#rid21">21</a>]. By six years of age, the adrenarchal increase in serum DHEAS is detectable by immunoassay (<a class="graphic graphic_table graphicRef75217" href="/d/graphic/75217.html" rel="external">table 1</a>). At a younger age, a small increase in serum DHEAS is detectable by liquid chromatography-tandem mass spectrometry [<a href="#rid21">21</a>] and a significant increase of DHEAS and its metabolites is detectable in urine [<a href="#rid22">22</a>].</p><p>Centripetal migration of proliferating precursor cells contributes to the enlargement of the zona reticularis [<a href="#rid20">20</a>]. By early adulthood, the cell proliferation wanes [<a href="#rid20">20</a>]. After 40 years of age, zona reticularis cell senescence predominates and the zone partially involutes, with consequent decreases in adrenal-derived production of DHEAS, DHEAS precursors, androstenedione, and testosterone [<a href="#rid23">23,24</a>].</p><p class="headingAnchor" id="H244930153"><span class="h2">Regulation of zona reticularis/adrenarchal growth, development, and function</span><span class="headingEndMark"> — </span>ACTH signaling is critical for the maintenance and function of the zona reticularis. Accordingly, ACTH deficiency reverses adrenarchal steroid secretion [<a href="#rid25">25,26</a>]. As an example, DHEA and DHEAS secretion declines rapidly after ACTH withdrawal (eg, due to glucocorticoid therapy) and is slow to resume after ACTH signaling is restored [<a href="#rid26">26</a>].</p><p>ACTH effects on adrenal androgen production are modulated by diverse signaling networks [<a href="#rid27">27,28</a>]. Modulators of the androgenic response to ACTH include a stimulatory isoform of DENND1A (DENN/MADD domain-containing protein 1A; DENND1A.V2) that is known to be overexpressed in theca cells in the setting of polycystic ovary syndrome. In addition, bone morphogenetic protein type 4 has an inhibitory influence. Interleukin-6, which stimulates ACTH secretion, is also strongly expressed in the zona reticularis of the adrenal cortex, where it directly stimulates production of all classes of adrenal steroids independently of ACTH [<a href="#rid29">29,30</a>]. Insulin and insulin-like growth factor 1 (IGF-1) stimulate expression of adrenal P450c17 and 3-beta-hydroxysteroid dehydrogenase type 2 activities [<a href="#rid31">31-33</a>]. Leptin, an adipocyte hormone, stimulates the 17,20-lyase activity of adrenocortical cells [<a href="#rid34">34</a>].</p><p>Prolactin may regulate the growth and function of the zona reticularis. This possibility is supported by the observation that adrenarche is severely attenuated in congenital pituitary disorders in which there is prolactin, but not ACTH, deficiency [<a href="#rid35">35,36</a>]. Conversely, hyperprolactinemia is accompanied by adrenal androgen excess [<a href="#rid37">37</a>]. These considerations suggest that an interaction between prolactin and ACTH amplifies adrenarche.</p><p>Postnatal body growth is related to adrenarche [<a href="#rid38">38-40</a>]. Nutritional status, in particular, seems to play a role in adrenarchal development, particularly in girls [<a href="#rid39">39,41</a>]. Obesity, particularly commencing with early childhood rapid weight gain, is associated with increased DHEAS levels in normal children [<a href="#rid42">42,43</a>]. Insulin, IGF-1, and leptin may mediate this relationship [<a href="#rid33">33,34,39</a>].</p><p>In contrast with postnatal growth, birth weight is inversely associated with adrenarchal DHEAS levels. Infants born small for gestational age have increased DHEAS levels at five to eight years of age, independent of obesity status. Conversely, children born large for gestational age have lower adrenarchal DHEAS levels than those with normal birth weight [<a href="#rid42">42,44</a>].</p><p>Ovarian function affects zona reticularis growth and DHEAS levels through unclear mechanisms. Puberty is associated with earlier expansion of the zona reticularis in females compared with males [<a href="#rid20">20</a>]. Ovariectomy precipitates an early decline in DHEAS levels that is unrelated to estrogenic status [<a href="#rid45">45</a>]. Paradoxically, primary ovarian failure is associated with an earlier rise in DHEAS levels (although later pubarche) [<a href="#rid46">46</a>]. The 50 percent higher serum DHEAS levels of men than women [<a href="#rid3">3</a>] seem explicable by higher testicular than ovarian secretion of DHEA, which is peripherally converted to DHEAS [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H975963105"><span class="h2">Basis of the biochemical changes of adrenarche</span><span class="headingEndMark"> — </span>The adrenarchal pattern of adrenal secretion in response to ACTH results from a unique steroidogenic enzyme expression profile in the zona reticularis that develops in mid-childhood (<a class="graphic graphic_figure graphicRef58179" href="/d/graphic/58179.html" rel="external">figure 3</a>) [<a href="#rid28">28</a>].</p><p>Beginning at approximately four to five years of age, zona reticularis cells express decreasing levels of 3-beta-hydroxysteroid dehydrogenase type 2 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613890&amp;token=87jLzclRwWxNoI%2BQq5Gg7ydITyxRIdJDyrDRJ%2FhhsZVz4GveQ0NqsIHz5NZWIJJs&amp;TOPIC_ID=5798" target="_blank"><i>HSD3B2</i></a>) but increasing levels of cytochrome b5 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613218&amp;token=87jLzclRwWxNoI%2BQq5Gg763r2g7MzYT6bIOr%2BiTCzdEjsBN%2FIIC%2BvEpZV2Q%2FqzvK&amp;TOPIC_ID=5798" target="_blank"><i>CYB5A</i></a>) and steroid sulfotransferase 2A1 [<a href="#rid49">49,50</a>], which promote DHEAS formation as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Low activity of 3-beta-hydroxysteroid dehydrogenase type 2 in the zona reticularis is associated with poor production of cortisol and other delta-4-steroids (eg, androstenedione and testosterone) in favor of formation of DHEAS and other delta-5-steroids (eg, DHEA, 17-hydroxypregnenolone, and pregnenolone). This enzyme activity is low in part because of low <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613890&amp;token=87jLzclRwWxNoI%2BQq5Gg7ydITyxRIdJDyrDRJ%2FhhsZVz4GveQ0NqsIHz5NZWIJJs&amp;TOPIC_ID=5798" target="_blank"><i>HSD3B2</i></a> gene expression [<a href="#rid49">49,51</a>] and in part because enzyme activity undergoes end-product inhibition in a dose-related manner, particularly by cortisol [<a href="#rid38">38</a>]. High fatty acid levels also seem to inhibit activity of this enzyme [<a href="#rid52">52</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased 17,20-lyase activity of cytochrome P450c17 in the zona reticularis also contributes to the adrenarchal changes [<a href="#rid51">51</a>]. Cytochrome P450c17 has two actions. The first is 17-alpha-hydroxylase activity, which catalyzes the conversion of pregnenolone to 17-hydroxypregnenolone (an essential precursor of both cortisol and sex steroids). The second is 17,20-lyase activity, which preferentially converts 17-hydroxypregnenolone (a C21 steroid) to DHEA (a C19 steroid) (<a class="graphic graphic_figure graphicRef58179" href="/d/graphic/58179.html" rel="external">figure 3</a>) [<a href="#rid17">17</a>]. Preferential expression of <em>CYB5A</em> in the zona reticularis catalyzes this enhancement of lyase activity of P450c17. (See  <a class="medical medical_review" href="/d/html/120.html" rel="external">"Adrenal steroid biosynthesis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The above factors favor the formation of DHEA from 17-hydroxypregnenolone by the zona reticularis. Meanwhile, preferential expression of steroid sulfotransferase 2A1 in this zone then converts DHEA to the relatively inert DHEAS, which acts to "trap" it and thus to direct steroidogenesis to this terminal product and to prevent DHEA from being converted into more biologically active androgens [<a href="#rid28">28</a>].</p><p></p><p>At approximately nine years of age, zona reticularis cells also increasingly express 17-beta-hydroxysteroid dehydrogenase type 5 (encoded by the aldo-keto reductase gene [<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603966&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr8eVfT5djOPLj6Cg5N7ZX4&amp;TOPIC_ID=5798" target="_blank"><i>AKR1C3</i></a>]) [<a href="#rid20">20,53</a>]. This enzyme appears to account for the small amount of adrenal testosterone secretion [<a href="#rid53">53</a>]. Testosterone and androstenedione are further metabolized within the zona reticularis by 11-beta-hydroxylase (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F610613&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2ByDmqq97Asg%2BSw2OnX4tfVVrGQlpQj1Wl1hDNWLhQe3&amp;TOPIC_ID=5798" target="_blank"><i>CYP11B1</i></a>), which underlies robust adrenal 11-beta-hydroxyandrostenedione and much lesser 11-beta-hydroxytestosterone secretion [<a href="#rid54">54</a>]. Small amounts of <a class="drug drug_general" data-topicid="107870" href="/d/drug information/107870.html" rel="external">estrone</a> are also formed by aromatase (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F107910&amp;token=tEpDslnpc0F0kICl%2Fz7sFc8JblQ%2BgdQqT9K%2Br8tS8thNM1VSWBc9z1Oklzy4%2BDWb&amp;TOPIC_ID=5798" target="_blank"><i>CYP19A1</i></a>) in the zona reticularis [<a href="#rid54">54,55</a>].</p><p class="headingAnchor" id="H1463996274"><span class="h2">Contribution of adrenarchal hormones to bioactive androgens</span><span class="headingEndMark"> — </span>The large quantities of C19 steroids, mostly 17-ketosteroid prohormones, secreted by the mature adrenal gland are, to a small extent, converted to more androgenic hormones in the peripheral circulation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testosterone</strong> – Approximately one-quarter of the serum testosterone of adult women arises by adrenal testosterone secretion and one-quarter by peripheral conversion of adrenal androstenedione; the remainder arises from the ovary [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>11-beta-hydroxyandrostenedione</strong> – In the zona reticularis, 11-beta-hydroxylase type 1 efficiently metabolizes androstenedione to 11-beta-hydroxyandrostenedione.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>11-ketoandrostenedione</strong> – In the kidney, 11-beta-hydroxyandrostenedione is converted to 11-ketoandrostenedione by 11-beta-hydroxysteroid dehydrogenase type 2 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F614232&amp;token=tEpDslnpc0F0kICl%2Fz7sFSbCnKy1I6QPXy4E96e7Dz5w6lm9XExxy5MX7hCqdsp9&amp;TOPIC_ID=5798" target="_blank"><i>HSD11B2</i></a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>11-ketotestosterone</strong> – In fat and other peripheral tissues, 11-ketoandrostenetione is efficiently reduced to 11-beta-hydroxytestosterone by 17-beta-hydroxysteroid dehydrogenase type 5 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603966&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr8eVfT5djOPLj6Cg5N7ZX4&amp;TOPIC_ID=5798" target="_blank"><i>AKR1C3</i></a>) [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>11-beta-hydroxysterosterone</strong> – A small amount of 11-beta-hydroxytestosterone, which has weak androgenic activity, is also generated either in the adrenal zona reticularis through 11-beta-hydroxylation of testosterone (by 11-beta-hydroxylase type 1) or more so in extra-adrenal tissues (liver, fat, etc) through reduction of 11-ketotestosterone via 11-beta-hydroxysteroid dehydrogenase type 1.</p><p></p><p>11-ketotestosterone predominates nearly threefold over testosterone in the serum of healthy young adrenarchal children [<a href="#rid57">57</a>]. 11-ketotestosterone has 33 to 101 percent of the androgenic biopotency of testosterone at physiologic concentrations [<a href="#rid54">54,58</a>]. Thus, 11-ketotestosterone contributes at least as much to serum androgenic bioactivity as testosterone during adrenarche.</p><p>Androgen action is often exerted by intracrine effects (ie, conversion to a more bioactive form in target organs). Testosterone is converted to dihydrotestosterone, which is approximately tenfold more potent in activating the androgen receptor, in androgen target organs by 5-alpha-reductase [<a href="#rid17">17</a>]. Although DHEAS is incapable of activating the androgen receptor, androgen-responsive skin expresses all of the enzymes necessary to convert DHEAS to dihydrotestosterone. This is particularly seen in the sebaceous gland, which has high 3-beta-hydroxysteroid dehydrogenase activity [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS OF ADRENARCHE</span><span class="headingEndMark"> — </span>Adrenarchal androgens contribute to the appearance of pubic hair (pubarche) and sebaceous gland and apocrine (sweat) gland development. Androgens are a prerequisite for the growth and development of the pilosebaceous unit (PSU) in "sexual" areas of skin [<a href="#rid59">59,60</a>]. Before puberty, the androgen-dependent PSU consists of a prepubertal vellus follicle in which the hair and sebaceous gland components are virtually invisible to the naked eye. When exposed to increasing androgen levels, the PSUs of sexual hair areas progressively switch to production of a thicker type of terminal hair follicle. In acne-prone areas, androgen causes the prepubertal vellus follicle to develop into a sebaceous gland.</p><p>These changes in the PSU lead to the following clinical manifestations of adrenarche:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin</strong> – Adrenarchal androgen action on sebaceous glands is first manifested clinically as microcomedonal acne, which is the basis of the change in facial complexion that occurs in mid-childhood.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Apocrine glands</strong> – Adrenarchal androgen action on apocrine glands is manifested as adult-type body odor.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pubarche</strong> – Pubic hair normally begins after eight years of age in girls and nine years in boys. Axillary hair ordinarily follows when androgen levels become slightly higher but occasionally precedes pubic hair development. Pubarche before eight years of age in girls and nine years in boys is the primary manifestation of premature adrenarche. (See  <a class="medical medical_review" href="/d/html/5806.html" rel="external">"Premature adrenarche"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other</strong> – Other effects of adrenarche have been suggested but are not established:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Puberty – Adrenarchal androgens may play a role in advancing the onset of puberty. Higher urinary excretion of dehydroepiandrosterone sulfate (DHEAS) and related 19-carbon (C19) steroids one to two years before puberty correlates with earlier onset of puberty [<a href="#rid61">61</a>]. Mid-childhood DHEAS levels are associated with earlier age of menarche independent of insulin-like growth factor 1 (IGF-1) and body mass index [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bone health – Adrenal androgens may promote bone mineral density and strength in children, as suggested by correlations between adrenal androgen levels and bone mineral parameters [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lipids – The data regarding a possible effect of the DHEAS elevation in obesity on serum lipids have led to conflicting conclusions [<a href="#rid41">41,64</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neurobiologic development – Other observations suggest that adrenarchal steroids might play a role in human neurobiologic development. Serum levels of dehydroepiandrosterone (DHEA) and testosterone differentially correlate with specific structural developmental changes in the cerebral corticolimbic system [<a href="#rid65">65</a>]. DHEAS and its precursor, pregnenolone sulfate, as well as the progesterone metabolite, allopregnanolone, have direct nongenomic neuroactive effects, which include modulation of neurotransmitter signaling and neuroplasticity [<a href="#rid2">2,66,67</a>]. These steroid sulfates are actively transported across the blood-brain barrier [<a href="#rid68">68</a>]. The association of adrenarchal changes with the emergence of sexually dimorphic sexual attraction and stress-adaptive and social maturational behavior during middle childhood, prior to true puberty, has led to the suggestion that adrenarchal steroids play a role in activating these behaviors [<a href="#rid69">69-71</a>].</p><p></p><p class="headingAnchor" id="H3533433905"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117619.html" rel="external">"Society guideline links: Normal puberty and puberty-related disorders"</a>.)</p><p class="headingAnchor" id="H24070796"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical context</strong> – Adrenarche is the maturational increase in adrenal androgens that is indexed by a rise in serum dehydroepiandrosterone sulfate (DHEAS) that becomes measurable by radioimmunoassay at approximately six years of age and earlier by liquid chromatography-tandem mass spectrometry. The clinical manifestations of adrenarche usually occur shortly after puberty begins but occasionally precede puberty because the processes are independent. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physiology</strong> – The biochemical changes of adrenarche result from qualitative changes in the secretory response to adrenocorticotropic hormone (ACTH) due to the development of the zona reticularis (<a class="graphic graphic_figure graphicRef138813" href="/d/graphic/138813.html" rel="external">figure 4</a>). (See <a class="local">'Physiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After adrenarche, ACTH causes a disproportionate rise in serum dehydroepiandrosterone (DHEA) and its delta-5-3-beta-hydroxysteroid precursors (eg, 17-hydroxypregnenolone) relative to serum testosterone, androstenedione, and their delta-4-3-ketosteroid precursors (eg, 17-hydroxyprogesterone and androstenedione). Conversely, suppression of ACTH by glucocorticoid administration disproportionately suppresses DHEAS more than cortisol. (See <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ACTH signaling is necessary for the development of the zona fasciculata and zona reticularis and for their steroid secretions. Birth weight is inversely related to adrenarchal development. Postnatal body growth, obesity, and prolactin are positively related to adrenarchal development. (See <a class="local">'Regulation of zona reticularis/adrenarchal growth, development, and function'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>These changes are related to the development of the zona reticularis and its unique steroidogenic enzyme expression pattern of low 3-beta-hydroxysteroid dehydrogenase type 2 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613890&amp;token=87jLzclRwWxNoI%2BQq5Gg7ydITyxRIdJDyrDRJ%2FhhsZVz4GveQ0NqsIHz5NZWIJJs&amp;TOPIC_ID=5798" target="_blank"><i>HSD3B2</i></a>) with high cytochrome b5 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613218&amp;token=87jLzclRwWxNoI%2BQq5Gg763r2g7MzYT6bIOr%2BiTCzdEjsBN%2FIIC%2BvEpZV2Q%2FqzvK&amp;TOPIC_ID=5798" target="_blank"><i>CYB5A</i></a>), sulfotransferase 2A1 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F125263&amp;token=87jLzclRwWxNoI%2BQq5Gg701BH4WBeuQt2XtrqowKQ7z2w8NLCkLMh03h6ELb3juv&amp;TOPIC_ID=5798" target="_blank"><i>SULT2A1</i></a>), and increased 17-beta-hydroxysteroid dehydrogenase type 5 (encoded by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603966&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr8eVfT5djOPLj6Cg5N7ZX4&amp;TOPIC_ID=5798" target="_blank"><i>AKR1C3</i></a><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603966&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyr8eVfT5djOPLj6Cg5N7ZX4&amp;TOPIC_ID=5798" target="_blank">)</a>. (See <a class="local">'Basis of the biochemical changes of adrenarche'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The 11-oxygenated 19-carbon (C19) steroids, particularly 11-beta-hydroxyandrostenedione and its active metabolite 11-ketotestosterone, have been identified as adrenarchal steroids. 11-ketotestosterone contributes at least as much to serum androgenic bioactivity as testosterone in young adrenarchal children. (See <a class="local">'Contribution of adrenarchal hormones to bioactive androgens'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Adrenarchal androgens normally account for the mid-childhood development of sebaceous and apocrine gland development and contribute to the appearance of pubic hair (pubarche). It is less clear whether adrenarche contributes to increased bone mineral density and prepubertal behavior patterns. (See <a class="local">'Clinical manifestations of adrenarche'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ibáñez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev 2000; 21:671.</a></li><li><a class="nounderline abstract_t">Rege J, Nanba AT, Auchus RJ, et al. Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro. J Clin Endocrinol Metab 2018; 103:320.</a></li><li><a class="nounderline abstract_t">Kulle AE, Reinehr T, Simic-Schleicher G, et al. Determination of 17OHPreg and DHEAS by LC-MS/MS: Impact of Age, Sex, Pubertal Stage, and BMI on the Δ5 Steroid Pathway. J Clin Endocrinol Metab 2017; 102:232.</a></li><li><a class="nounderline abstract_t">Nguyen AD, Mapes SM, Corbin CJ, Conley AJ. Morphological adrenarche in rhesus macaques: development of the zona reticularis is concurrent with fetal zone regression in the early neonatal period. J Endocrinol 2008; 199:367.</a></li><li><a class="nounderline abstract_t">Nakamura Y, Gang HX, Suzuki T, et al. Adrenal changes associated with adrenarche. Rev Endocr Metab Disord 2009; 10:19.</a></li><li><a class="nounderline abstract_t">Conley AJ, Bernstein RM, Nguyen AD. Adrenarche in nonhuman primates: the evidence for it and the need to redefine it. J Endocrinol 2012; 214:121.</a></li><li><a class="nounderline abstract_t">Quinn TA, Ratnayake U, Dickinson H, et al. The feto-placental unit, and potential roles of dehydroepiandrosterone (DHEA) in prenatal and postnatal brain development: A re-examination using the spiny mouse. J Steroid Biochem Mol Biol 2016; 160:204.</a></li><li><a class="nounderline abstract_t">Dumontet T, Sahut-Barnola I, Septier A, et al. PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal. JCI Insight 2018; 3.</a></li><li><a class="nounderline abstract_t">Campbell B. DHEAS and Human Development: An Evolutionary Perspective. Front Endocrinol (Lausanne) 2020; 11:101.</a></li><li><a class="nounderline abstract_t">Biro FM, Huang B, Daniels SR, Lucky AW. Pubarche as well as thelarche may be a marker for the onset of puberty. J Pediatr Adolesc Gynecol 2008; 21:323.</a></li><li><a class="nounderline abstract_t">Rich BH, Rosenfield RL, Lucky AW, et al. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 1981; 52:1129.</a></li><li><a class="nounderline abstract_t">Rosenfield RL. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair. J Pediatr 1971; 79:260.</a></li><li><a class="nounderline abstract_t">Weber A, Clark AJ, Perry LA, et al. Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche. Clin Endocrinol (Oxf) 1997; 46:431.</a></li><li><a class="nounderline abstract_t">Rittmaster RS, Givner ML. Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women. J Clin Endocrinol Metab 1988; 67:400.</a></li><li><a class="nounderline abstract_t">Brigell DF, Fang VS, Rosenfield RL. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab 1992; 74:1036.</a></li><li><a class="nounderline abstract_t">Rosenfield RL. Normal and Premature Adrenarche. Endocr Rev 2021; 42:783.</a></li><li><a class="nounderline abstract_t">Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32:81.</a></li><li><a class="nounderline abstract_t">Novoselova TV, Hussain M, King PJ, et al. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. FASEB J 2018; :fj201701274RR.</a></li><li><a class="nounderline abstract_t">Pignatti E, Altinkilic EM, Bräutigam K, et al. Cholesterol Deprivation Drives DHEA Biosynthesis in Human Adrenals. Endocrinology 2022; 163.</a></li><li><a class="nounderline abstract_t">Hui XG, Akahira J, Suzuki T, et al. Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence. J Endocrinol 2009; 203:241.</a></li><li><a class="nounderline abstract_t">Kim JH, Lee YA, Lim YH, et al. Changes in Adrenal Androgens and Steroidogenic Enzyme Activities From Ages 2, 4, to 6 Years: A Prospective Cohort Study. J Clin Endocrinol Metab 2020; 105.</a></li><li><a class="nounderline abstract_t">Remer T, Boye KR, Hartmann MF, Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab 2005; 90:2015.</a></li><li><a class="nounderline abstract_t">Nanba AT, Rege J, Ren J, et al. 11-Oxygenated C19 Steroids Do Not Decline With Age in Women. J Clin Endocrinol Metab 2019; 104:2615.</a></li><li><a class="nounderline abstract_t">Nunes-Souza E, Silveira ME, Mendes MC, et al. From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset. Endocr Connect 2020; 9:1212.</a></li><li><a class="nounderline abstract_t">Korth-Schutz S, Levine LS, New MI. Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion. J Clin Endocrinol Metab 1976; 42:1005.</a></li><li><a class="nounderline abstract_t">Cutler GB Jr, Davis SE, Johnsonbaugh RE, Loriaux DL. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. J Clin Endocrinol Metab 1979; 49:604.</a></li><li><a class="nounderline abstract_t">Udhane SS, Flück CE. Regulation of human (adrenal) androgen biosynthesis-New insights from novel throughput technology studies. Biochem Pharmacol 2016; 102:20.</a></li><li><a class="nounderline abstract_t">Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016; 37:467.</a></li><li><a class="nounderline abstract_t">Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998; 19:101.</a></li><li><a class="nounderline abstract_t">Päth G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab 1997; 82:2343.</a></li><li><a class="nounderline abstract_t">Endoh A, Kristiansen SB, Casson PR, et al. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996; 81:3558.</a></li><li><a class="nounderline abstract_t">l'Allemand D, Penhoat A, Lebrethon MC, et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab 1996; 81:3892.</a></li><li><a class="nounderline abstract_t">Baquedano MS, Berensztein E, Saraco N, et al. Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Pediatr Res 2005; 58:451.</a></li><li><a class="nounderline abstract_t">Biason-Lauber A, Zachmann M, Schoenle EJ. Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche. Endocrinology 2000; 141:1446.</a></li><li><a class="nounderline abstract_t">Taha D, Mullis PE, Ibáñez L, de Zegher F. Absent or delayed adrenarche in Pit-1/POU1F1 deficiency. Horm Res 2005; 64:175.</a></li><li><a class="nounderline abstract_t">Van Hulle S, Craen M, Callewaert B, et al. Delayed Adrenarche may be an Additional Feature of Immunoglobulin Super Family Member 1 Deficiency Syndrome. J Clin Res Pediatr Endocrinol 2016; 8:86.</a></li><li><a class="nounderline abstract_t">Glickman SP, Rosenfield RL, Bergenstal RM, Helke J. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab 1982; 55:251.</a></li><li><a class="nounderline abstract_t">Majzoub JA, Topor LS. A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol. Horm Res Paediatr 2018; 89:311.</a></li><li><a class="nounderline abstract_t">Guercio G, Rivarola MA, Chaler E, et al. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 2003; 88:1389.</a></li><li><a class="nounderline abstract_t">Palmert MR, Hayden DL, Mansfield MJ, et al. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001; 86:4536.</a></li><li><a class="nounderline abstract_t">Mäntyselkä A, Lindi V, Viitasalo A, et al. Associations of Dehydroepiandrosterone Sulfate With Cardiometabolic Risk Factors in Prepubertal Children. J Clin Endocrinol Metab 2018; 103:2592.</a></li><li><a class="nounderline abstract_t">Ong KK, Potau N, Petry CJ, et al. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004; 89:2647.</a></li><li><a class="nounderline abstract_t">Corvalán C, Uauy R, Mericq V. Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight. Am J Clin Nutr 2013; 97:318.</a></li><li><a class="nounderline abstract_t">Nordman H, Voutilainen R, Antikainen L, Jääskeläinen J. Prepubertal children born large for gestational age have lower serum DHEAS concentrations than those with a lower birth weight. Pediatr Res 2017; 82:285.</a></li><li><a class="nounderline abstract_t">Cumming DC, Rebar RW, Hopper BR, Yen SS. Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 1982; 54:1069.</a></li><li><a class="nounderline abstract_t">Martin DD, Schweizer R, Schwarze CP, et al. The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome. J Clin Endocrinol Metab 2004; 89:1164.</a></li><li><a class="nounderline abstract_t">Luu-The V, Dufort I, Paquet N, et al. Structural characterization and expression of the human dehydroepiandrosterone sulfotransferase gene. DNA Cell Biol 1995; 14:511.</a></li><li><a class="nounderline abstract_t">Forti G, Toscano V, Casilli D, et al. Spermatic and peripheral venous plasma concentrations of testosterone, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone, delta 5-androstene-3 beta,17 beta-diol, dihydrotestosterone, 5 alpha-androstane-3 alpha,17 beta-diol, 5 alpha-androstane-3 beta,17 beta-diol, and estradiol in boys with idiopathic varicocele in different stages of puberty. J Clin Endocrinol Metab 1985; 61:322.</a></li><li><a class="nounderline abstract_t">Rainey WE, Carr BR, Sasano H, et al. Dissecting human adrenal androgen production. Trends Endocrinol Metab 2002; 13:234.</a></li><li><a class="nounderline abstract_t">Rege J, Nakamura Y, Wang T, et al. Transcriptome profiling reveals differentially expressed transcripts between the human adrenal zona fasciculata and zona reticularis. J Clin Endocrinol Metab 2014; 99:E518.</a></li><li><a class="nounderline abstract_t">Suzuki T, Sasano H, Takeyama J, et al. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000; 53:739.</a></li><li><a class="nounderline abstract_t">Bellanger S, Battista MC, Fink GD, Baillargeon JP. Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells. Steroids 2012; 77:347.</a></li><li><a class="nounderline abstract_t">Nakamura Y, Hornsby PJ, Casson P, et al. Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009; 94:2192.</a></li><li><a class="nounderline abstract_t">Rege J, Nakamura Y, Satoh F, et al. Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab 2013; 98:1182.</a></li><li><a class="nounderline abstract_t">Moreau F, Mittre H, Benhaim A, et al. Aromatase expression in the normal human adult adrenal and in adrenocortical tumors: biochemical, immunohistochemical, and molecular studies. Eur J Endocrinol 2009; 160:93.</a></li><li><a class="nounderline abstract_t">Turcu AF, Rege J, Auchus RJ, Rainey WE. 11-Oxygenated androgens in health and disease. Nat Rev Endocrinol 2020; 16:284.</a></li><li><a class="nounderline abstract_t">Rege J, Turcu AF, Kasa-Vubu JZ, et al. 11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche. J Clin Endocrinol Metab 2018; 103:4589.</a></li><li><a class="nounderline abstract_t">Storbeck KH, Bloem LM, Africander D, et al. 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer? Mol Cell Endocrinol 2013; 377:135.</a></li><li><a class="nounderline abstract_t">Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21:363.</a></li><li><a class="nounderline abstract_t">Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005; 353:2578.</a></li><li><a class="nounderline abstract_t">Remer T, Shi L, Buyken AE, et al. Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing. J Clin Endocrinol Metab 2010; 95:3002.</a></li><li><a class="nounderline abstract_t">Thankamony A, Ong KK, Ahmed ML, et al. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. J Clin Endocrinol Metab 2012; 97:E786.</a></li><li><a class="nounderline abstract_t">Remer T, Boye KR, Hartmann M, et al. Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children. J Bone Miner Res 2003; 18:1539.</a></li><li><a class="nounderline abstract_t">Pereira A, Merino PM, Santos JL, et al. High DHEAS in girls and metabolic features throughout pubertal maturation. Clin Endocrinol (Oxf) 2022; 96:419.</a></li><li><a class="nounderline abstract_t">Nguyen TV. Developmental effects of androgens in the human brain. J Neuroendocrinol 2018; 30.</a></li><li><a class="nounderline abstract_t">Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992; 6:2311.</a></li><li><a class="nounderline abstract_t">Schverer M, Lanfumey L, Baulieu EE, et al. Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases. Pharmacol Ther 2018; 191:190.</a></li><li><a class="nounderline abstract_t">Grube M, Hagen P, Jedlitschky G. Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters. Front Pharmacol 2018; 9:354.</a></li><li><a class="nounderline abstract_t">Campbell BC. Adrenarche and middle childhood. Hum Nat 2011; 22:327.</a></li><li><a class="nounderline abstract_t">Del Giudice M. Sex, attachment, and the development of reproductive strategies. Behav Brain Sci 2009; 32:1.</a></li><li><a class="nounderline abstract_t">Herdt G, McClintock M. The magical age of 10. Arch Sex Behav 2000; 29:587.</a></li></ol></div><div id="topicVersionRevision">Topic 5798 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11133068" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Premature adrenarche--normal variant or forerunner of adult disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29126147" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Adrenocorticotropin Acutely Regulates Pregnenolone Sulfate Production by the Human Adrenal In Vivo and In Vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27809697" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Determination of 17OHPreg and DHEAS by LC-MS/MS: Impact of Age, Sex, Pubertal Stage, and BMI on theΔ5 Steroid Pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18787057" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Morphological adrenarche in rhesus macaques: development of the zona reticularis is concurrent with fetal zone regression in the early neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18821019" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Adrenal changes associated with adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22378920" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adrenarche in nonhuman primates: the evidence for it and the need to redefine it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26485665" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The feto-placental unit, and potential roles of dehydroepiandrosterone (DHEA) in prenatal and postnatal brain development: A re-examination using the spiny mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29367455" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32194506" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : DHEAS and Human Development: An Evolutionary Perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19064225" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pubarche as well as thelarche may be a marker for the onset of puberty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6262366" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Adrenarche: changing adrenal response to adrenocorticotropin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4327052" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9196605" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2969002" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1314844" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33788946" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Normal and Premature Adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21051590" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29879378" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35583599" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cholesterol Deprivation Drives DHEA Biosynthesis in Human Adrenals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19723922" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32750115" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Changes in Adrenal Androgens and Steroidogenic Enzyme Activities From Ages 2, 4, to 6 Years: A Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15671100" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30753518" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : 11-Oxygenated C19 Steroids Do Not Decline With Age in Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33112833" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/180041" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/225347" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26498719" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Regulation of human (adrenal) androgen biosynthesis-New insights from novel throughput technology studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27459230" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9570034" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9215317" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8855801" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8923834" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16148056" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10746649" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210857" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Absent or delayed adrenarche in Pit-1/POU1F1 deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26757742" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Delayed Adrenarche may be an Additional Feature of Immunoglobulin Super Family Member 1 Deficiency Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6282921" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29847819" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629134" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11549704" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29757399" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Associations of Dehydroepiandrosterone Sulfate With Cardiometabolic Risk Factors in Prepubertal Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15181036" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23283497" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Obesity is positively associated with dehydroepiandrosterone sulfate concentrations at 7 y in Chilean children of normal birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28419081" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prepubertal children born large for gestational age have lower serum DHEAS concentrations than those with a lower birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6460782" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15001603" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7598806" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Structural characterization and expression of the human dehydroepiandrosterone sulfotransferase gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3159746" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Spermatic and peripheral venous plasma concentrations of testosterone, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone, delta 5-androstene-3 beta,17 beta-diol, dihydrotestosterone, 5 alpha-androstane-3 alpha,17 beta-diol, 5 alpha-androstane-3 beta,17 beta-diol, and estradiol in boys with idiopathic varicocele in different stages of puberty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12128283" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Dissecting human adrenal androgen production.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24423296" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Transcriptome profiling reveals differentially expressed transcripts between the human adrenal zona fasciculata and zona reticularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11155097" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22245830" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19336506" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23386646" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18974231" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Aromatase expression in the normal human adult adrenal and in adrenocortical tumors: biochemical, immunohistochemical, and molecular studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32203405" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : 11-Oxygenated androgens in health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30137510" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : 11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23856005" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : 11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10950157" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Role of hormones in pilosebaceous unit development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16354894" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Clinical practice. Hirsutism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20371661" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22419724" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12929945" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34904249" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : High DHEAS in girls and metabolic features throughout pubertal maturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28489322" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Developmental effects of androgens in the human brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1347506" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Neuroactive steroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29953900" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29695968" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22388879" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Adrenarche and middle childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19210806" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Sex, attachment, and the development of reproductive strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11100264" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The magical age of 10.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
